Villanova, PA, United States of America

Dmitry Gabrilovich

USPTO Granted Patents = 8 

 

 

Average Co-Inventor Count = 2.2

ph-index = 1

Forward Citations = 3(Granted Patents)


Company Filing History:


Years Active: 2018-2025

Loading Chart...
Loading Chart...
Loading Chart...
8 patents (USPTO):Explore Patents

Title: The Innovative Contributions of Dmitry Gabrilovich

Introduction

Dmitry Gabrilovich is a prominent inventor based in Villanova, PA, known for his significant contributions to the field of cancer research. With a remarkable portfolio of 8 patents, his work primarily centers around innovative therapeutic methods and biological applications that aim to combat malignancies.

Latest Patents

Among his recent inventions, Gabrilovich has developed a variant survivin vaccine aimed at treating myeloma. This invention comprises a double mutant form of the survivin polypeptide, along with nucleic acid molecules that encode this variant. The technology involves antigen presenting cells such as dendritic cells, as well as methods for treating malignancies or inducing immune responses using the variant survivin polypeptide or nucleic acid sequences.

Another notable patent involves the use of lactoferrin for generating myeloid-derived suppressor cells (MDSCs) ex vivo, where blood cells are cultured with lactoferrin to enhance their effectiveness in immune suppression.

Career Highlights

Gabrilovich has played an integral role in advancing cancer therapies during his tenure at renowned institutions such as The Wistar Institute of Anatomy & Biology and the H. Lee Moffitt Cancer Center and Research Institute, Inc. His innovative spirit and dedication to research have made significant impacts in the understanding and treatment of cancer.

Collaborations

Throughout his career, Gabrilovich has collaborated with distinguished colleagues, including Frederick L. Locke and Scott Antonia. These partnerships have facilitated groundbreaking research and paved the way for novel therapeutic approaches in oncology.

Conclusion

Dmitry Gabrilovich exemplifies the essence of innovation in the field of cancer research. His patents and collaborative efforts have contributed to the development of new therapeutic strategies that hold promise for improving patient outcomes. As he continues to explore the frontiers of biological research, his work remains a vital part of the ongoing fight against cancer.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…